🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 27876L107
- Market Cap
- Micro Cap · $33 Million
Business: Echo Therapeutics, Inc. is a transdermal medical device company with deep expertise in advanced skin permeation technology. Echo is developing their PreludeTM SkinPrep System as a platform technology to allow for significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction. Utilizing the patented, core skin permeation technology found in Prelude, Echo is developing its needle-free SymphonyTM tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for use in hospital critical care units and for people with diabetes.
Notes: 6/6/013 -- Echo Therapeutics Announces a 1-for-10 Reverse Split of Common Stock
Company Contact
- CEO
- Scott Wayne Hollander
- CFO
- Alan W. Schoenbart
- Headquarters
- 88 Wood Avenue South, Iselin, NJ 02038
- Phone
- 732-549-0919
- Investor Relations
- Christine Olimpio · 732-549-0128 · colimpio@echotx.com